Table 3.
iNOS | COX-2 | Fas | Bcl-xl | Active caspase 3 | |
Patient A | |||||
Normal mucosa | 1 | 0 | 1 | 1 | Positive |
Ca, T3N1M0 | 2 | 1 | 1 | 0 | Positive |
Patient B | |||||
Normal mucosa | 1 | 1 | 1 | 1 | Positive |
Ca, T3N0M0 | 2 | 2 | 1 | 0 | Positive |
Patient C | |||||
Normal mucosa | 1 | 1 | 1 | 0 | Positive |
Ca, T3N0M0 | 3 | 1 | 1 | 0 | Positive |
Patient D | |||||
Normal mucosa | 1 | 1 | 1 | 1 | Positive |
Ca, T3N2M0 | 1 | 0 | 1 | 0 | Positive |
Immunohistochemical score: 0, 0%; 1, 0–10%; 2, 10–50%; 3, 50–100%.
Ca, carcinoma; COX-2, cyclooxygenase 2; iNOS, inducible nitric oxide synthase.